These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19275539)

  • 1. The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and development.
    Cipolla L; Polissi A; Airoldi C; Galliani P; Sperandeo P; Nicotra F
    Curr Drug Discov Technol; 2009 Mar; 6(1):19-33. PubMed ID: 19275539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface.
    Cipolla L; Polissi A; Airoldi C; Gabrielli L; Merlo S; Nicotra F
    Curr Med Chem; 2011; 18(6):830-52. PubMed ID: 21182480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Biological Signature for the Inhibition of Outer Membrane Lipoprotein Biogenesis.
    Lehman KM; Smith HC; Grabowicz M
    mBio; 2022 Jun; 13(3):e0075722. PubMed ID: 35695460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
    Chopra I; Schofield C; Everett M; O'Neill A; Miller K; Wilcox M; Frère JM; Dawson M; Czaplewski L; Urleb U; Courvalin P
    Lancet Infect Dis; 2008 Feb; 8(2):133-9. PubMed ID: 18222164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are outer-membrane targets the solution for MDR Gram-negative bacteria?
    Walker SS; Black TA
    Drug Discov Today; 2021 Sep; 26(9):2152-2158. PubMed ID: 33798647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery strategies to outer membrane targets in Gram-negative pathogens.
    Brown DG
    Bioorg Med Chem; 2016 Dec; 24(24):6320-6331. PubMed ID: 27178386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis.
    Hammond SM; Claesson A; Jansson AM; Larsson LG; Pring BG; Town CM; Ekström B
    Nature; 1987 Jun 25-Jul 1; 327(6124):730-2. PubMed ID: 3037377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Agents That Inhibit the Outer Membrane Assembly Machines of Gram-Negative Bacteria.
    Choi U; Lee CR
    J Microbiol Biotechnol; 2019 Jan; 29(1):1-10. PubMed ID: 29996592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.
    Liu F; Ma S
    Mini Rev Med Chem; 2018; 18(4):310-323. PubMed ID: 27739357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastering the Gram-negative bacterial barrier - Chemical approaches to increase bacterial bioavailability of antibiotics.
    Ropponen HK; Richter R; Hirsch AKH; Lehr CM
    Adv Drug Deliv Rev; 2021 May; 172():339-360. PubMed ID: 33705882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein Transport: Greasing the Machines of Outer Membrane Biogenesis: Re-Examining Lipoprotein Transport Mechanisms Among Diverse Gram-Negative Bacteria While Exploring New Discoveries and Questions.
    Grabowicz M
    Bioessays; 2018 Apr; 40(4):e1700187. PubMed ID: 29512860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics].
    Collet JF
    Bull Mem Acad R Med Belg; 2009; 164(7-9):213-20; discussion 220. PubMed ID: 20218188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance.
    Romano KP; Hung DT
    Biochim Biophys Acta Mol Cell Res; 2023 Mar; 1870(3):119407. PubMed ID: 36543281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation of the 2-keto-3-deoxymanno-octulosonic acid (Kdo) biosynthesis pathway between plants and bacteria.
    Smyth KM; Marchant A
    Carbohydr Res; 2013 Oct; 380():70-5. PubMed ID: 23974348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466.
    Cuny GD
    Expert Opin Ther Pat; 2009 Jun; 19(6):893-9. PubMed ID: 19473108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in development of antibiotics against Gram-negative bacteria].
    Xu ZQ; Xu ZY
    Yao Xue Xue Bao; 2013 Jul; 48(7):993-1004. PubMed ID: 24133966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).
    Supuran CT; Carta F; Scozzafava A
    Expert Opin Ther Pat; 2013 Jul; 23(7):777-88. PubMed ID: 23458841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of 3-deoxy-manno-octulosonate cytidylyltransferase from Haemophilus influenzae complexed with the substrate 3-deoxy-manno-octulosonate in the beta-configuration.
    Yoon HJ; Ku MJ; Mikami B; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2008 Dec; 64(Pt 12):1292-4. PubMed ID: 19018107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and challenges in bacterial compound accumulation assays for drug discovery.
    Six DA; Krucker T; Leeds JA
    Curr Opin Chem Biol; 2018 Jun; 44():9-15. PubMed ID: 29803973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.